These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3003946)

  • 1. [Criteria for the selection of drugs for the pathogenetic treatment of Itsenko-Cushing disease].
    Slavnov VN; Luchitskiĭ EV; Cheban AK
    Ter Arkh; 1985; 57(12):36-9. PubMed ID: 3003946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a single dose of parlodel on the secretion of various hormones in Itsenko-Cushing disease].
    Slavnov VN; Markov VV; Luchitskiĭ EV; Iakovlev AA; Komissarenko IV
    Probl Endokrinol (Mosk); 1988; 34(5):19-23. PubMed ID: 2851139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurotensin in Itsenko-Cushing disease].
    Slavnov VN; Luchitskiĭ EV; Iakovlev AA; Komissarenko IV; Valueva GV
    Probl Endokrinol (Mosk); 1984; 30(4):35-40. PubMed ID: 6382246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the secretion of the hormones of the hypothalamo-hypophyseo-adrenal system in Itsenko-Cushing disease under the influence of insulin-induced hypoglycemia and thyroliberin].
    Slavnov VN; Luchitskiĭ EV
    Vrach Delo; 1990 Mar; (3):72-5. PubMed ID: 2164280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamics of beta-lipotropin and beta-endorphin levels in Itsenko-Cushing disease patients being treated with the antiserotonin preparation cyproheptadine (peritol) and chloditan].
    Slavnov VN; Valueva GV; Luchitskiĭ EV
    Ter Arkh; 1984; 56(9):119-22. PubMed ID: 6096979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamics of secretion of hypothalamo-hypophyseal system hormones in Itsenko-Cushing disease as affected by combination therapy].
    Slavnov VN; Valueva GV; Luchitskiĭ EV; Komissarenko IV; Cheban AK
    Probl Endokrinol (Mosk); 1983; 29(6):28-32. PubMed ID: 6140677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potential use of the antiserotonin preparation cyproheptadine (peritol) in Itsenko-Cushing disease].
    Valueva GV; Luchitskiĭ EV; Iakovlev AA
    Farmakol Toksikol; 1983; 46(2):50-3. PubMed ID: 6852218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of cyproheptadine (Peritol) as a drug blocking corticotropin secretion in the treatment of Cushing's syndrome].
    Komissarenko IV; Cheban AK; Rybakov SI; Pomerantsev IuV; Slavnov VI
    Probl Endokrinol (Mosk); 1981; 27(6):39-42. PubMed ID: 6275378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
    Slavnov VN; Valueva GV; Luchitsky EV
    Exp Clin Endocrinol; 1985 Jun; 85(3):341-50. PubMed ID: 2995088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of cyproheptadine (peritol) as a drug blocking corticotropin secretion in the treatment of Itsenko-Cushing's disease.
    Komissarenko IV; Cheban AK; Rybakov SI; Pomerantsev YuV ; Slavnov VI; Luchitskii EV
    Neurosci Behav Physiol; 1982; 12(6):494-6. PubMed ID: 6314174
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prolactin secretion in Itsenko-Cushing disease patients treated with chloditan and peritol].
    Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Cheban AK
    Probl Endokrinol (Mosk); 1982; 28(4):39-44. PubMed ID: 7122445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing syndrome in dogs: treatment with bromocriptine and cyproheptadine.
    Richkind M
    Vet Med Small Anim Clin; 1981 Sep; 76(9):1301-4. PubMed ID: 6277079
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental and clinical basis for using the preparation nacom in the treatment of Itsenko-Cushing disease].
    Slavnov VN; Valueva GV; Luchitskiĭ EV; Iakovlev AA; Cheban AK
    Probl Endokrinol (Mosk); 1986; 32(2):70-4. PubMed ID: 3012515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bromocryptin in the treatment of Itsenko-Cushing's disease].
    Vasiukova EA; Zefirova GS; Ibragimova GV; Mkrtumian AM; Khaĭkina MB
    Sov Med; 1979 Jun; (6):65-9. PubMed ID: 224516
    [No Abstract]   [Full Text] [Related]  

  • 15. [The treatment of the climacteric syndrome in women suffering from Itsenko-Cushing disease and primary obesity].
    Manusharova RA
    Lik Sprava; 1992 Jan; (1):94-6. PubMed ID: 1364624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Response to thyroliberin of prolactin, corticotropin and cortisol among women with Itsenko-Cushing disease].
    Manusharova RA; Komissarenko IV; Veĭnberg EG; Slavnov VN; Cheban AK
    Vrach Delo; 1986 Jan; (1):94-7. PubMed ID: 3006352
    [No Abstract]   [Full Text] [Related]  

  • 17. [Function of the hypophysis in patients with Itsenko-Cushing disease treated with peritol and chloditan].
    Slavnov VN; Valueva GV; Luchitskiĭ EV
    Klin Med (Mosk); 1983 Oct; 61(10):27-31. PubMed ID: 6417399
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and biochemical remission of Itsenko-Cushing disease during parlodel treatment].
    Marova EI; Butrova SA; Pronin VS
    Sov Med; 1978 Jun; (6):91-4. PubMed ID: 354026
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of GABA-ergic preparations on the function of the hypothalamo-hypophyseal-adrenal system in patients with Itsenko-Cushing disease].
    Mishunina TM; Kononenko VIa; Komissarenko IV; Luchitskiĭ EV
    Probl Endokrinol (Mosk); 1991; 37(4):28-31. PubMed ID: 1664951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The function of the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing syndrome].
    Luchitskiĭ EV; Valueva GV; Markov VV; Slavnov VN; Rybakov SI
    Probl Endokrinol (Mosk); 1989; 35(6):38-42. PubMed ID: 2560186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.